Global X China Medtech ETF (HKG:2841)

Assets	11.97M
Expense Ratio	0.68%
PE Ratio	25.53
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-21.81%

Volume	300
Open	40.58
Previous Close	39.82
Day's Range	40.58 - 40.58
52-Week Low	33.90
52-Week High	53.04
Beta	0.51
Holdings	31
Inception Date	Aug 3, 2023

About 2841

2841.HK was created on 2023-08-03 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Sub-Fund is to provide investment results that, before fees and expenses, closely correspond to the performance of the Solactive China MedTech Index (the Index).

• Asset Class: Equity
• Category: Theme
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2841
• Provider: Global X
• Index Tracked: Solactive China MedTech Index - CNH - Benchmark TR Net

Performance

2841 had a total return of -21.81% in the past year, including dividends. Since the fund's inception, the average annual return has been -9.24%.

Top 10 Holdings

59.83% of assets

Name	Symbol	Weight
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.	300760	9.32%
Aier Eye Hospital Group Co., Ltd.	300015	8.11%
JD Health International Inc.	6618	8.02%
Shanghai United Imaging Healthcare Co., Ltd.	688271	7.67%
Genscript Biotech Corporation	1548	7.61%
Shenzhen New Industries Biomedical Engineering Co., Ltd.	300832	4.34%
Alibaba Health Information Technology Limited	0241	4.12%
Andon Health Co., Ltd.	002432	3.85%
APT Medical Inc.	688617	3.54%
Intco Medical Technology Co., Ltd.	300677	3.25%

Data Sources: S&P Global Market Intelligence, Twelve Data, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error